| Line Item | 2025-01-26 | Y/Y |
|---|---|---|
| Revenue | $130.50B | +114.2% |
| Cost of Revenue | $32.64B | +96.4% |
| Gross Profit | $97.86B | +120.9% |
| R&D Expense | $12.91B | +48.9% |
| SG&A Expense | $3.49B | +31.5% |
| Operating Income | $81.45B | +147.0% |
| Pre-tax Income | $84.03B | +148.5% |
| Income Tax | $11.15B | +174.7% |
| Net Income | $72.88B |
| Line Item | 2025-01-26 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.59B | +18.0% |
| Short-term Investments | $34.62B | +85.1% |
| Accounts Receivable | $23.07B | +130.7% |
| Inventory | $10.08B | +90.8% |
| Current Assets | $80.13B | +80.7% |
| Total Assets | $111.60B | +69.8% |
| Current Liabilities | $18.05B | +69.8% |
| Line Item | 2025-01-26 | Y/Y |
|---|---|---|
| Operating Cash Flow | $64.09B | +128.2% |
| Investing Cash Flow | -$20.42B | -93.3% |
| Financing Cash Flow | -$42.36B | -210.7% |
| +144.9% |
| EPS (Basic) | $2.97 | -75.4% |
| EPS (Diluted) | $2.94 | -75.4% |
| Long-term Debt |
| $8.46B |
| -12.8% |
| Total Liabilities | $32.27B | +41.9% |
| Stockholders' Equity | $79.33B | +84.6% |